Estimación de la prevalencia de infección por VIH-1 en la embarazada y efectividad de la zidovudina administrada durante la gestación en la prevención de la transmisión vertical

Ramos Amador, José Tomás; Ruiz Contreras, Jesús; Bastero, Rafael; Barrio, Carmen; Moreno, Pilar; Delgado, Rafael; Muñoz, Eloy; Jiménez, Jesús.
Med. clín (Ed. impr.) ; 114(8): 286-291, mar. 2000.
Artículo en Es | IBECS (España) | ID: ibc-6308

Documentos relacionados

  1. Sustainable Protocol for the Synthesis of 2',3'-Dideoxynucleoside and 2',3'-Didehydro-2',3'-dideoxynucleoside Derivatives.
  2. The Use of Zidovudine Pharmacophore in Multi-Target-Directed Ligands for AIDS Therapy.
  3. Development of Triazoles and Triazolium Salts Based on AZT and Their Anti-Viral Activity against HIV-1.
  4. Fevipiprant (QAW039) does not affect the pharmacokinetics of zidovudine, its glucuronide, and penicillin G via inhibition of UGT2B7 and/or OAT3.
  5. Zidovudine (azidothymidine, AZT) unexpressed clinical potential against multidrug-resistant Gram-negative isolates.
  6. Zidovudine, a brief history before the first antirretroviral in Mexico.
  7. Nucleocapsid Protein Precursors NCp9 and NCp15 Suppress ATP-Mediated Rescue of AZT-Terminated Primers by HIV-1 Reverse Transcriptase.
  8. Safety of zidovudine/lamivudine scored tablets in children with HIV infection in Europe and Thailand.
  9. Thymidine analogue excision and discrimination modulated by mutational complexes including single amino acid deletions of Asp-67 or Thr-69 in HIV-1 reverse transcriptase.
  10. Chromatographic performance of zidovudine imprinted polymers coated silica stationary phases.